04
2 known investors
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.